-
Mashup Score: 0
Prefibrotic myelofibrosis is the focus of “SOHO State of the Art Updates and Next Questions.”
Source: bloodcancerstoday.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 6The HemOnc Pulse Live | Blood Cancers Today - 5 hour(s) ago
Hosted by Chadi Nabhan, MD, the inaugural HemOnc Pulse Live will address unanswered questions in hematologic malignancies May 3-4 in Chicago.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet-
👏 We're only a few days away from #HOPLive24! 🎙️ Whether you're looking forward to the #bispecifics panel with @Rfonsi1, @mrbishop_UC_BMT, & @AaronGoodman33, or the #AML panel with @Daver_Leukemia & @MikkaelSekeres, there's lots in store! 🙌 Learn more: https://t.co/MydFt6GkqD https://t.co/3BeiSNz1vO
-
-
Mashup Score: 5What Is the Role of Palliative Care in Pediatric Patients with Blood Cancers? | Blood Cancers Today - 23 hour(s) ago
Palliative care facilitates communication and helps with symptom management, the researchers noted.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 1Who Is the Right Patient for CAR-T Therapy? - 1 day(s) ago
A roundtable discussion, moderated by Thomas Martin, MD, of the UCSF Helen Diller Family Comprehensive Cancer Center, focused on CAR T-cell therapy considerations in the treatment of multiple myeloma, including data on approved CAR-T options and a look at the pipeline. Dr. Martin was joined by a panel that included Sagar Lonial, MD, FACP; Peter Voorhees, MD; and Shambavi Richard, MD. In the next segment of the roundtable series, Drs. Martin and Voorhees discuss patient characteristics and populations
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 6The HemOnc Pulse Live | Blood Cancers Today - 1 day(s) ago
Hosted by Chadi Nabhan, MD, the inaugural HemOnc Pulse Live will address unanswered questions in hematologic malignancies May 3-4 in Chicago.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet-
👏 We're only a few days away from #HOPLive24! 🎙️ Whether you're looking forward to the #bispecifics panel with @Rfonsi1, @mrbishop_UC_BMT, & @AaronGoodman33, or the #AML panel with @Daver_Leukemia & @MikkaelSekeres, there's lots in store! 🙌 Learn more: https://t.co/MydFt6GkqD https://t.co/3BeiSNz1vO
-
-
Mashup Score: 1SIMPLIFY-1: Momelotinib Leads to Higher Transfusion Independence in MF | Blood Cancers Today - 1 day(s) ago
Momelotinib achieved higher rates of transfusion independence compared with ruxolitinib.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 4Guillermo Garcia-Manero, MD, Reflects on National Cancer Prevention and Early Detection Month | Blood Cancers Today - 2 day(s) ago
Early detection and prevention are particularly important in leukemia, Dr. Garcia-Manero explained.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 6The HemOnc Pulse Live | Blood Cancers Today - 2 day(s) ago
Hosted by Chadi Nabhan, MD, the inaugural HemOnc Pulse Live will address unanswered questions in hematologic malignancies May 3-4 in Chicago.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet-
👏 We're only a few days away from #HOPLive24! 🎙️ Whether you're looking forward to the #bispecifics panel with @Rfonsi1, @mrbishop_UC_BMT, & @AaronGoodman33, or the #AML panel with @Daver_Leukemia & @MikkaelSekeres, there's lots in store! 🙌 Learn more: https://t.co/MydFt6GkqD https://t.co/3BeiSNz1vO
-
-
Mashup Score: 3What Is the Role of Splenic Irradiation Before HSCT in Patients With MF? | Blood Cancers Today - 2 day(s) ago
Splenic irradiation before HSCT is associated with reduced spleen size and lower incidence of relapse in patients with MF.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 1Geoff Chong, MD, Shares Data on Novel Bispecific Antibody in Follicular Lymphoma | Blood Cancers Today - 3 day(s) ago
The ELM-2 trial studied odronextamab in patients with relapsed or refractory follicular lymphoma.
Source: bloodcancerstoday.comCategories: General Medicine News, Onc News and JournalsTweet
What is prefibrotic #myelofibrosis and how is it diagnosed and treated? @bose_prithviraj, of @MDAndersonNews, gives a rundown of the disease, which is also the focus of “SOHO State of the Art Updates and Next Questions.” @SocietyofHemOnc 📺 https://t.co/O1JhSSr6Iz https://t.co/vpIbFAD8AT